Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 114 EP applications Richard Ian Clegg has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 18, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11724832

IMPLANTABLE MEDICAL DEVICES HAVING MICROPOROUS SURFACE LAYERS AND METHOD FOR REDUCING FOREIGN BODY RESPONSE TO THE SAME

IPC classification:
A61L 27/02, A61L 27/16, A61L 27/52, A61L 27/56
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11751374

APTAMERS TO 4-1BB AND THEIR USE IN TREATING DISEASES AND DISORDERS

IPC classification:
C07H 21/02, A61K 48/00
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP11791932

CYANOQUINOLINE DERIVATIVES

IPC classification:
A61P 35/00, C07D 401/12, C07D 401/14, C07D 405/12, A61K 31/4709, A61K 31/497, A61K 31/506, A61K 31/5377
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
The patent has been granted
EP12159080

Antibodies binding to an intracellular PRL-1 or PRL-3 polypeptide

IPC classification:
A61P 35/00, C07K 16/18, A61K 39/395
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11840099

POLYCOMB-ASSOCIATED NON-CODING RNAS

IPC classification:
C12N 15/113
Applicant:
Massachusetts General Hospital
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11769451

5-POSITION MODIFIED PYRIMIDINES AND THEIR USE

IPC classification:
C07H 19/073, C07H 19/10, C07H 21/04
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11852141

POLYCOMB-ASSOCIATED NON-CODING RNAS

IPC classification:
C12N 15/113
Applicant:
Massachusetts General Hospital
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11832854

COMBINATION TREATMENT OF CANCER

IPC classification:
A61P 35/00, A61K 31/52
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12754934

APTAMERS FOR CLOSTRIDIUM DIFFICILE DIAGNOSTICS

IPC classification:
C07H 21/00, G01N 33/53
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12790157

BLOCKADE OF TL1A-DR3 INTERACTIONS TO AMELIORATE T CELL MEDIATED DISEASE PATHOLOGY AND ANTIBODIES THEREOF

IPC classification:
A61P 11/06, A61P 19/02, C12N 15/62, A61K 39/395
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP12806953

RNA-YY1 INTERACTIONS

IPC classification:
A61P 35/00, C07H 21/02, C07H 21/04, C40B 40/06, C40B 50/06, G01N 33/68, A61K 31/7105, A61K 31/711
Applicant:
Massachusetts General Hospital
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12823662

DEVICE AND METHOD TO ACCURATELY AND EASILY ASSEMBLE GLASS SLIDES

IPC classification:
C12M 1/34
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12825069

A PROTEIN INVOLVED IN DETECTION OF CANCER METASTASIS AND A TREATMENT THEREOF

IPC classification:
A61P 35/04, C07K 16/18, C12N 15/113, C12Q 1/68, G01N 33/533, A61K 38/17, A61K 39/00
Applicant:
National University of Singapore
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12836076

CARDIOVASCULAR RISK EVENT PREDICTION AND USES THEREOF

IPC classification:
G01N 33/48, G01N 33/52
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11745411

ISOLATION OF BIOMOLECULES FROM BIOLOGICAL SAMPLES

IPC classification:
C12N 15/10, C12Q 1/68
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12840785

IRON-FIBER COMPOSITION, PREPARATION AND USES THEREOF

IPC classification:
B32B 9/00
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12843012

SELECTION OF PREFERRED SAMPLE HANDLING AND PROCESSING PROTOCOL FOR IDENTIFICATION OF DISEASE BIOMARKERS AND SAMPLE QUALITY ASSESSMENT

IPC classification:
C12M 1/34
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP12863462

APTAMERS AND DIAGNOSTIC METHODS FOR DETECTING THE EGF RECEPTOR

IPC classification:
C12N 15/115, C12Q 1/68, A61K 31/7072
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12167750

Herpes Simplex Virus for the treatment of liver cancer

IPC classification:
A61P 35/00, A61K 31/4412, A61K 31/704, A61K 35/76
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13761420

ADJUVANT AND VACCINE COMPOSITIONS

IPC classification:
A61K 39/39
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13775956

RNA APTAMERS FOR THERAPEUTIC AND DIAGNOSTIC DELIVERY TO PANCREATIC CANCER CELLS

IPC classification:
C07H 21/02, C12N 15/115, C12Q 1/68, A61K 31/7088
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13774934

TUBERCULOSIS BIOMARKERS AND USES THEREOF

IPC classification:
C12Q 1/68
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13720737

VASCULAR ENDOTHELIAL GROWTH FACTOR ANTAGONISTS AND METHODS FOR THEIR USE

IPC classification:
C07K 14/71, A61K 38/18
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13724345

HERPES SIMPLEX VIRUS FOR THE TREATMENT OF LIVER CANCER

IPC classification:
A61P 35/00, A61K 31/4412, A61K 31/704, A61K 35/76
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13801106

APTAMER-BASED MULTIPLEXED ASSAYS

IPC classification:
C07H 21/00, C12Q 1/68, G01N 33/543
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP14194459

Aptamer therapeutics useful in the treatment of complement-related disorders

IPC classification:
C12N 15/115, C12Q 1/68, A61K 31/7088
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11835619

POLYMORPH OF N-(6-(4-CHLOROPHENOXY)HEXYL)-N'-CYANO-N''-(4-PYRIDYL)GUANIDINE, AND PREPARATION THEREFOR AND USE THEREOF

IPC classification:
A61P 35/00, C07D 213/74, A61K 31/4409
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13830027

USE OF P47 FROM PLASMODIUM FALCIPARUM (PFS47) OR PLASMODIUM VIVAX (PVS47) AS A VACCINE OR DRUG SCREENING TARGETS FOR THE INHIBITION OF HUMAN MALARIA TRANSMISSION

IPC classification:
C07K 14/445, C12N 15/30, C12N 15/63, G01N 33/15, A61K 39/015
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13836396

MULTIFUNCTIONAL ORAL VACCINE BASED ON CHROMOSOME RECOMBINEERING

IPC classification:
A61P 31/04, C12N 1/21, C12N 15/31, A61K 35/74
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11849550

NOVEL SUBSTITUTED BICYCLIC AROMATIC COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS

IPC classification:
A61P 11/06, C07C 65/105, C07C 65/24, C07D 213/79, C07D 215/06, C07D 215/20, C07D 217/16, C07D 239/28, C07D 253/10, C07D 401/04, C07D 401/10, C07D 405/04, C07D 409/14, A61K 31/216
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Agent:
Tara Romaine Jennings, F. R. Kelly & Co.
Status:
EXAMINATION IN PROGRESS
EP11849278

NOVEL SUBSTITUTED BICYCLIC AROMATIC COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS

IPC classification:
A61P 11/06, C07C 65/24, C07D 213/79, C07D 215/06, C07D 215/20, C07D 215/60, C07D 217/16, C07D 239/28, C07D 241/24, C07D 253/10, C07D 401/04, C07D 401/10, C07D 403/10, A61K 31/4709, A61K 31/498
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP10857614

NOVEL DIHYDROPYRIMIDIN-2(1H)-ONE COMPOUNDS AS NEUROKININ-3 RECEPTOR ANTAGONISTS

IPC classification:
A61P 9/00, A61P 11/00, A61P 17/00, A61P 21/00, A61P 23/00, A61P 25/00, A61P 27/00, A61P 29/00, A61P 31/00, A61P 37/00, A61P 39/00, A61K 31/505
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14198571

Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics

IPC classification:
C12N 15/11
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15152547

Chemically modified aptamers with improved off-rates

IPC classification:
C12Q 1/68
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13871817

BIDIRECTIONAL WRENCH

IPC classification:
B25B 13/46
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14743879

METHODS AND KITS FOR TREATING AND CLASSIFYING INDIVIDUALS AT RISK OF OR SUFFERING FROM A NEUROLOGICAL DYSFUNCTION OR DISORDER

IPC classification:
A61P 25/28, C12Q 1/48, C12Q 1/68
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15166660

DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS

IPC classification:
C07K 14/00, C07K 14/16, C07K 14/47, C12N 9/90, C12N 15/113, C12N 15/85, C12N 15/867, A01K 67/027, A61K 35/28, A61K 48/00
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15158380

KITS COMPRISING APTAMERS

IPC classification:
C12N 15/115, G01N 33/53
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13709799

ASSAY FOR DETERMINING THE CELL NUMBER IN CULTURED CELLS

IPC classification:
G01N 33/50
Applicant:
Keele University
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14761246

SELF ASSEMBLING BETA-BARREL PROTEINS POSITION NANOTUBES

IPC classification:
B82Y 30/00, C08H 1/00, C08J 9/228
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14765516

BRIDGED BICYCLIC NUCLEOSIDES

IPC classification:
C07H 21/04, C12N 15/11
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14768310

LOCKED NUCLEIC ACID INHIBITOR OF MIR-145 AND USES THEREOF

IPC classification:
A61K 31/712
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15184135

Peptides deriving from Alternaria Alternata major allergen Alt a 1

IPC classification:
C07K 14/37, C07K 14/415, C07K 14/435, A61K 39/35
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14782975

METHOD FOR DETECTING PROTEIN STABILITY AND USES THEREOF

IPC classification:
C07K 2/00, C12N 15/62, C12N 15/65, G01N 21/64
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14783395

POLYCAPROLACTONE MICROCARRIERS FOR STEM CELL CULTURE AND FABRICATION THEREOF

IPC classification:
C12N 5/02, C12N 5/0735, C12N 5/074, C12N 5/0775, A61L 27/40
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14761117

METAL ION-FUNCTIONAL FIBER COMPONENT COMPLEX COMPOSITIONS, PREPARATION AND USES THEREOF

IPC classification:
A61P 3/02, B32B 9/00, C07F 15/02, A23L 33/16, A61K 33/24
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14765389

MYCELIATED COFFEE PRODUCTS AND METHODS FOR MAKING

IPC classification:
A23L 33/00, A23F 5/02
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15188374

DEVICES AND METHODS OF CELL CAPTURE AND ANALYSIS

IPC classification:
C12Q 1/02, G01N 33/53, G01N 33/574
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Agent:
Cooley (UK) LLP
Status:
The patent has been granted
EP14794681

SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR

IPC classification:
C07D 239/48
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13884688

HEPARAN SULPHATES

IPC classification:
A61P 19/08, C08B 37/10, C12P 19/04, A61K 31/727
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13150168

Aptamer therapeutics useful in the treatment of complement-related disorders

IPC classification:
C12N 15/115, C12Q 1/68, A61K 31/7088
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14808338

COMPOSITION FOR MAINTAINING PLATELET FUNCTION

IPC classification:
A61P 7/00, A61K 31/4439, A61K 31/444, A61K 35/14
Applicant:
Kyoto University
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14805119

HEPARAN SULPHATE

IPC classification:
C08B 37/10, C12N 5/02, A61F 2/00, A61K 31/727
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14806840

(+)-5-(3,4-DIFLUOROPHENYL)-5-[(3-METHYL-2-OXOPYRIDIN-1(2H)-YL)METHYL]IMIDAZOLIDINE-2,4-DIONE AND DRUG CONTAINING SAME

IPC classification:
A61P 17/00, A61P 17/06, A61P 17/10, A61P 37/08, C07B 57/00, C07D 401/06, A61K 9/06, A61K 9/08, A61K 31/4439, A61K 47/10
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14810407

METHODS AND KITS FOR TREATING AND CLASSIFYING INDIVIDUALS AT RISK OF OR SUFFERING FROM TRAP1 CHANGE-OF-FUNCTION

IPC classification:
C12Q 1/68
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14817065

HIGH-STABILITY T-CELL RECEPTOR AND PREPARATION METHOD AND APPLICATION THEREOF

IPC classification:
A61P 31/12, A61P 35/00, A61P 37/06, C07K 14/725, C12N 15/10, C12N 15/12, C12N 15/63, A61K 38/17, A61K 47/48
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14822991

NICOTINE SALT WITH M ETA-SALICYLIC ACID

IPC classification:
F24J 1/00, A61K 9/00, A61M 15/06
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15189979

STABILIZED APTAMERS TO PLATELET DERIVED GROWTH FACTOR AND THEIR USE AS ONCOLOGY THERAPEUTICS

IPC classification:
C07K 14/715, C12N 15/11, C12N 15/115, A61K 31/337, A61K 31/427, A61K 31/4745, A61K 31/522, A61K 31/704, A61K 31/7048, A61K 31/7072, A61K 38/17
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION PUBLISHED
EP15191232

COMPLEMENT BINDING APTAMERS AND ANTI-C5 AGENTS USEFUL IN THE TREATMENT OF OCULAR DISORDERS

IPC classification:
C12N 15/115, A61K 48/00
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11753699

USE OF MARKERS OF UNDIFFERENTIATED PLURIPOTENT STEM CELLS

IPC classification:
C07D 409/14, C12N 5/0735
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12173138

Complement binding aptamers and anti-C5 agents useful in the treatment of ocular disorders

IPC classification:
C12N 15/115, A61K 48/00
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10845390

DIASTEREOMERS OF 10-PROPARGYL-10-DEAZAAMINOPTERIN FOR USE IN THE TREATMENT OF LUNG CANCER

IPC classification:
A61P 35/00, C07D 475/08, A61K 31/519
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14781343

QUANTUM MOLECULAR SEQUENCING (QM-SEQ): IDENTIFICATION OF UNIQUE NANOELECTRONIC TUNNELING SPECTROSCOPY FINGERPRINTS FOR DNA, RNA, AND SINGLE NUCLEOTIDE MODIFICATIONS

IPC classification:
C12Q 1/68
Applicant:
The Regents of the University of Colorado
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP14847780

MULTIAPTAMER TARGET DETECTION

IPC classification:
C12N 15/115
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14854788

NANOPARTICLE COMPOSITIONS AND METHODS AS CARRIERS OF NUTRACEUTICAL FACTORS ACROSS CELL MEMBRANES AND BIOLOGICAL BARRIERS

IPC classification:
A61K 38/00
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14853519

YAP PROTEIN INHIBITING POLYPEPTIDE AND APPLICATION THEREOF

IPC classification:
A61P 35/00, C07K 7/08, C07K 14/00, A61K 38/10
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11831651

NOVEL SUBSTITUTED QUINOLINE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS

IPC classification:
A61P 11/00, C07D 215/20, C07D 401/04, C07D 401/10, C07D 409/04, C07D 409/14, C07D 413/10, C07D 417/10, A61K 31/47, A61K 31/4709
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Agent:
Anna-Louise Hally, F. R. Kelly & Co.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11807317

NOVEL DIHYDROPYRIDIN-2(1H)-ONE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS AND NEUROKININ-3 RECEPTOR ANTAGONISTS

IPC classification:
C07D 211/88, C07D 213/22, C07D 401/04, C07D 409/04, C07D 409/14, A61K 31/715
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11828028

DRILL HEAD LOCKING APPARATUS AND DRILL HEAD

IPC classification:
A61B 17/16
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13167177

Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function

IPC classification:
C12Q 1/68, A61K 31/23, A61K 31/7004
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11708094

SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO}METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE

IPC classification:
C07C 57/145, C07C 309/19, C07D 487/06, A61K 31/55, A61K 45/06
Applicant:
Pfizer Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13167178

Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function

IPC classification:
C12Q 1/68, G01N 33/48, A61K 31/12
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13167176

Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function

IPC classification:
C12Q 1/68, G01N 33/48, A61K 31/12
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13167174

Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function

IPC classification:
C12Q 1/68, G01N 33/48, A61K 31/12
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13167175

Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function

IPC classification:
C12Q 1/68, G01N 33/48, A61K 31/12
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14864118

CYTIDINE-5-CARBOXAMIDE MODIFIED NUCLEOTIDE COMPOSITIONS AND METHODS RELATED THERETO

IPC classification:
C07H 19/06
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11769393

APTAMERS TO ss-NGF AND THEIR USE IN TREATING ss-NGF MEDIATED DISEASES AND DISORDERS

IPC classification:
C07H 19/073, C07H 19/10, C07H 21/04, C12N 15/115
Applicant:
Otsuka Pharmaceutical Co., Ltd.
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP14868495

POLYCARBONATES BEARING AROMATIC N-HETEROCYCLES FOR DRUG DELIVERY

IPC classification:
C08G 64/16, A61K 9/51, A61K 31/704, A61K 31/7088, A61K 38/00, A61K 47/34
Applicant:
International Business Machines Corporation (IBM)
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13158346

Detection methods using aptamers

IPC classification:
G01N 33/53
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15701655

MUTAGENESIS METHODS

IPC classification:
C12N 9/22, C12N 15/10, C12N 15/63
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15737714

USE OF PARP INHIBITORS TO TREAT BREAST OR OVARIAN CANCER PATIENTS SHOWING A LOSS OF HETEROZYGOSITY

IPC classification:
C12Q 1/68
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14873831

COGENERATION PLANT

IPC classification:
E04H 5/02, E04H 5/10, E04H 5/12, F01K 23/10, F25B 27/02
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14877091

1-(3-AMINOPROPYL) SUBSTITUTED CYCLIC AMINE COMPOUNDS, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

IPC classification:
A61P 31/18, C07D 401/14, C07D 409/14, C07D 451/04, C07D 519/00, A61K 31/454, A61K 31/4545, A61K 31/46
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15751799

COMPOSITIONS AND METHODS FOR DETECTING MICROORGANISMS

IPC classification:
C12Q 1/68, C40B 30/04, C40B 40/06, G01N 33/00, G01N 33/566
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP10845917

CHROMONE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE

IPC classification:
A61P 9/00, A61P 9/12, A61P 11/00, A61P 11/06, C07D 311/36, A61K 31/352
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11742796

NOVEL S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS

IPC classification:
A01N 43/16, A61K 31/352, A61K 31/381, A61K 31/382, A61K 31/41, A61K 31/4245, A61K 31/433
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15786841

HEPARAN SULPHATES

IPC classification:
A61P 17/02, A61P 19/08, C07K 14/495, C08B 37/10, C12N 5/077, C12P 19/04, A01N 1/00, A61K 31/727, A61L 27/10
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15721808

ONCOLYTIC VIRUS AND AURORA KINASE INHIBITOR FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/416, A61K 35/763
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15799703

CRYSTALLINE POWDER OF CYCLIC PEPTIDE COMPOUND, PREPARATION METHOD FOR SAME, AND USES THEREOF

IPC classification:
A61P 31/10, C07K 1/02, C07K 7/56, A61K 38/12
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15729302

NUCLEIC ACID COMPOUNDS FOR BINDING TO COMPLEMENT COMPONENT 3 PROTEIN

IPC classification:
C12N 15/115, A61K 31/7088
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15800606

CRYSTAL OF CYCLIC PEPTIDE COMPOUND, PREPARATION METHOD FOR SAME, AND USES THEREOF

IPC classification:
A61P 31/10, C07K 1/02, C07K 7/56, A61K 38/12
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16183844

SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO}METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE

IPC classification:
A61P 35/00, C07C 57/145, C07C 309/19, C07D 487/06, A61K 31/55, A61K 45/06
Applicant:
Pfizer Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP14894623

RATCHET TOOL

IPC classification:
B25B 15/04, B25B 23/18
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15811279

STEM CELL SUBPOPULATIONS WITH DIFFERENTIAL GSTT1 EXPRESSION OR GENOTYPE

IPC classification:
C12N 5/0735, C12N 5/074, C12N 5/0775, C12Q 1/68, A61K 35/545
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15833096

HIGH DOSAGE STRENGTH TABLETS OF RUCAPARIB

IPC classification:
A61K 31/55
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15771320

THERAPEUTIC NANOPARTICLES AND RELATED COMPOSITIONS, METHODS AND SYSTEMS

IPC classification:
A61K 9/107, A61K 9/51, A61K 48/00
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15845666

NOVEL HIGH EFFICIENCY LIBRARY-IDENTIFIED AAV VECTORS

IPC classification:
C07H 21/04, C07K 14/00, C12N 15/00, C40B 40/06, A61K 48/00
Applicant:
University of Massachusetts
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15778721

DISPLAY ARRANGEMENT

IPC classification:
A63B 71/06, A63B 71/12, G02B 7/00, G09F 21/02, A45F 5/02
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15850708

HIGH ACTIVITY TUMOUR INHIBITOR AND PREPARATION METHOD AND USE THEREOF

IPC classification:
A61P 35/00, C07K 7/08, C07K 14/00, A61K 38/10, A61K 38/16
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15850028

RNA APTAMERS AGAINST TRANSFERRIN RECEPTOR (TFR)

IPC classification:
C07H 21/02, A61K 48/00
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16204982

METHOD AND APPARATUS FOR VAPORIZING A COMPOUND

IPC classification:
F24J 1/00, A24F 47/00, A61M 11/04, A61M 15/00, A61M 15/06
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
The application has been published
EP15852798

RECOMBINANT AAV VARIANTS AND USES THEREOF

IPC classification:
C12N 15/09, C12N 15/63, C12N 15/86, A61K 35/76
Applicant:
University of Massachusetts
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15854404

ANTI-TIM-3 ANTIBODIES

IPC classification:
A61P 31/00, A61P 35/00, A61P 37/00, C07K 16/28, A61K 39/395
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15855595

ANTI-PD-1 ANTIBODIES

IPC classification:
A61P 31/00, C07K 16/28, A61K 35/00, A61K 39/395
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15855010

ANTI-TIM-3 ANTIBODIES

IPC classification:
A61P 31/00, A61P 35/00, A61P 37/00, C07K 16/28, A61K 39/395
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16744838

TREATMENT OF CANCER BY INFUSION OF ONCOLYTIC HERPES SIMPLEX VIRUS TO THE BLOOD

IPC classification:
A61P 35/00, A61K 9/00, A61K 35/763, A61K 35/768, A61K 39/395, A61K 45/06
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15862096

HEPARAN SULPHATES FOR USE IN REPAIR AND/OR REGENERATION OF SKIN

IPC classification:
A61P 17/02, C08B 37/10, A61K 31/727
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15869319

ARTIFICIAL MULTI-ANTIGEN FUSION PROTEIN AND PREPARATION AND USE THEREOF

IPC classification:
A61P 31/04, A61P 31/12, C07K 19/00, A61K 39/02, A61K 39/118, A61K 39/12
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15826045

SALICYLATE COMPOUND COMPOSITION

IPC classification:
A61P 9/00, A61P 29/00, A61P 35/00, A61K 9/00, A61K 9/08, A61K 31/616, A61K 47/14
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16735235

ANTI-PD-L1 ANTIBODIES

IPC classification:
A61P 37/02, C07K 16/28, A61K 39/395
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16735241

PDGF-B /PDGF-BB BINDING VARIANTS OF HEPARAN SULPHATES

IPC classification:
A61P 17/02, C08B 37/00, A61K 31/727
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16737617

MONOCLONAL ANTIBODY AGAINST MURAMYL PEPTIDES IN PREVENTION AND TREATMENT OF IMMUNE-MEDIATED DISEASES

IPC classification:
A61P 31/00, A61P 37/08, C07K 16/12, A61K 39/02, A61K 39/085
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16740697

COMPOSITIONS AND METHODS FOR CANCER IMMUNOTHERAPY

IPC classification:
A61K 47/61, A61K 39/39, A61K 39/395
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15880740

MANUAL TOOL HAVING RELIABLE CONNECTION

IPC classification:
B25F 1/00, B25G 1/10, B25G 3/26
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature